CLSD Stock 15.36 Clearside Biomedi Cmn $CLSD Hit a 52 week

Fosun Pharma's Bold Move Well, if this isn't Fosun Pharma making some noise! Announcing an H-share repurchase plan worth up to HK$1 billion is like setting off fireworks amidst any investor's evening. They're hollering to the market, 'We see value, and we're doubling down on it.' Crunching the Numbers In the first half of 2026, Fosun Pharma's numbers weren't just a flash...

The Big Leap: Harbour BioMed Joins Stock Connect Well, if this ain't something to get excited about—Harbour BioMed just snagged a spot on the Stock Connect roster. This step isn't just ceremonial. We're talking about real access for mainland Chinese investors to dive directly into the shares of Harbour BioMed (HKEX: 02142.HK) through the Shanghai-Hong Kong and...

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Media Heavyweights Converge in Shenzhen Picture this: Over 400 media moguls from the Asia-Pacific region, huddled together in Shenzhen under that blazing September sun. What for? They're on a mission, inspecting China's shifting landscape, hunting down fresh growth avenues in the Guangdong-Hong Kong-Macao Greater Bay Area. It kicks off within the walls of the Asia-Pacific...

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Mounting Threats in Mountain Chains That nightmare on August 26 at Mount Langtang Lirung in Nepal—where an ice-rock avalanche triggered a catastrophic mudslide—brought a harsh reminder that these mountains are cracking wide open. With 31 dead and over 500 souls still unaccounted for, it's a chilling warning about how vulnerable high-altitude regions have become. A...

An Intriguing Move For Baidu's Class A Shares Well, here we go again, folks. Another move on the chessboard for Baidu. They've just walked their Class A ordinary shares onto the Shenzhen-Hong Kong and Shanghai-Hong Kong Stock Connects. As of today, September 7, 2026, mainland investors can now get their mitts on these shares more easily. It might not be a...

Important Information Regarding the Annual General Meeting The Annual General Meeting of Prosafe SE is set to occur at 08:30 a.m. CEST. This meeting aims to bring together shareholders to discuss the company's performance and future strategies. Virtual Meeting Arrangements For convenience, the annual meeting will be conducted virtually using the Lumi platform....

Revolutionary Usability of ZENEO® Auto-Injector in Critical Situations In an impressive achievement, Crossject has successfully conducted a pivotal human factors study showcasing the usability of its ZENEO® Midazolam auto-injector. This innovative device is set to be marketed globally under the name ZEPIZURE®. The study emulated high-stress conditions akin to a...

Revamping Workforce Strategies with a Human-Centered Approach Talent Solutions Right Management, a key player in the global talent management space, has debuted an innovative framework dubbed "The Right Way." This transformative approach emphasizes the importance of aligning business strategies with workforce development, a critical factor for sustained organizational...

Revolutionizing Video Surveillance with AI Innovations Leading surveillance providers are now leveraging Zilliz Cloud to tackle data overload challenges effectively. This advancement is enabling real-time threat detection and sub-second video search capabilities across various enterprise installations. Significant Adoption of Zilliz Vector Database Solutions Zilliz, the...

Concerns Over the Proposed Sale of Arch Resources, Inc. In the world of corporate mergers and acquisitions, it’s vital for shareholders to be aware of the implications involved in any proposed sale. Recently, the focus has turned to Arch Resources, Inc. (NYSE: ARCH), as the former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., and his law firm, Kahn Swick &...